Why the study?
The study aimed to evaluate brain natriuretic peptide levels in patients with type 2 diabetes mellitus presenting with diastolic dysfunction and various patterns of left ventricular remodeling.
Is brain natriuretic peptide (BNP) elevated in patients with type 2 diabetes mellitus and moderate arterial hypertension who have diastolic dysfunction and left ventricular remodeling but no clinical signs of heart failure?
Is brain natriuretic peptide (BNP) elevated in patients with type 2 diabetes mellitus and moderate arterial hypertension who have diastolic dysfunction and left ventricular remodeling but no clinical signs of heart failure?
BNP levels are significantly elevated in patients with type 2 diabetes and moderate hypertension who have diastolic dysfunction and unfavorable left ventricular remodeling, even in the absence of clinical heart failure.
Elevated BNP signals subclinical diastolic dysfunction in T2DM with hypertension; leaves open whether measurement aids early detection or risk stratification.
Objective: of article was to study the level of cerebral natriuretic peptide in patients with type 2 diabetes mellitus with diastolic dysfunction and with various types of left ventricular remodeling. Materials and methods: 256 patients with type 2 diabetes mellitus (DM) who had moderate arterial hypertension (AH) and no clinical signs of chronic heart failure were examined. The control group consisted of 30 practically healthy persons, comparable in age and sex with the examined patients. All patients were determined the concentration of brain natriuretic peptide (BNP) in blood plasma. The structural and functional parameters of the heart were determined by echocardiography in B- and M-modes according to the standard technique. Results: in patients with type 2 diabetes and diastolic dysfunction, the BNP concentration was 156 (84; 228) pg / ml, in patients without diastolic filling disorders — 24 (12; 38) pg / ml. The highest BNP values were found in the subgroup of patients with a restrictive type of transmitral flow. Also, BNP values were higher in the group of patients with concentric and eccentric left ventricular (LV) hypertrophy. Conclusion: in all patients with type 2 diabetes and concomitant moderate hypertension, even in the absence of clinical signs of CHF, there is an increase in the BNP level compared to the control group. The highest BNP values were observed in patients with severe diastolic dysfunction and unfavorable variants of LV remodeling.
No takes yet. Share an insight, caveat, or question.
Крутиков et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: